LOW-VOLUME · HOSP-HEAVY
glycopyrrolate Side Effects
glycopyrrolate (also sold as Seebri, Lonhala) is a LOW-VOLUME FAERS extract #391 of 524 by FAERS report count. Still opens on HOSP-HEAVY: 42.4% mention hospitalization (2,218 reports).
Data updated 2026-05-15
- 5,225
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
glycopyrrolate: 42.4% mention hospitalization (2,218 reports). Death stamp DEATH-HEAVY; volume band LOW-VOLUME #391 of 524 by FAERS report count.
Thinner FAERS extract for glycopyrrolate (Seebri) (5,225 reports #391 of 524 by FAERS report count). 42.4% mention hospitalization (2,218 reports). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2001–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
DYSPNOEA leads 1,000 of 5,225 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (1,066 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (630 reports, 12.1%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 237 |
| PNEUMONIA | 56 |
| DYSPNOEA | 50 |
| RESPIRATORY FAILURE | 47 |
| CARDIAC ARREST | 36 |
| DISEASE PROGRESSION | 35 |
| ASTHENIA | 34 |
| DIARRHOEA | 30 |
| CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 28 |
| FATIGUE | 28 |
| FALL | 27 |
| ACUTE KIDNEY INJURY | 22 |
| WEIGHT DECREASED | 22 |
| PAIN | 21 |
| SEPSIS | 21 |
| PRURITUS | 20 |
| VOMITING | 19 |
| ACUTE RESPIRATORY FAILURE | 18 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (2,218, 42.4% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| DYSPNOEA | 524 |
| ASTHMA | 413 |
| PNEUMONIA | 397 |
| WHEEZING | 388 |
| COUGH | 267 |
| CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 252 |
| CONDITION AGGRAVATED | 200 |
| FATIGUE | 198 |
| NAUSEA | 193 |
| CHEST DISCOMFORT | 191 |
| THERAPEUTIC PRODUCT EFFECT INCOMPLETE | 184 |
| VOMITING | 184 |
| PYREXIA | 172 |
| ASTHENIA | 153 |
| PRODUCTIVE COUGH | 148 |
| LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES | 147 |
| GASTROOESOPHAGEAL REFLUX DISEASE | 145 |
| FALL | 140 |
How to read glycopyrrolate FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 5,225 voluntary reports linked to glycopyrrolate (Seebri, Lonhala), 2001-2025. Death is listed on 630 (12.1%). Hospitalization appears on 2,218 (42.4%). Top co-reported indication: Product Used For Unknown Indication.
Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.
Read with glycopyrrolate
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 5,230 FAERS cases (Δ 5 heavier vs glycopyrrolate); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 5,207 FAERS cases (Δ 18 lighter vs glycopyrrolate); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 5,119 FAERS cases (Δ 106 lighter vs glycopyrrolate); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 5,342 FAERS cases (Δ 117 heavier vs glycopyrrolate); DEATH-MARKED · HOSP-MID · FEMALE-LED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 50.1 pp vs glycopyrrolate's DEATH-HEAVY): CASELOAD · HOSP-MID.
glycopyrrolate stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload WATCHLIST and the label guide.